BGI Genomics

World-Leading Genomic Sequencing & Proteomic Solutions

BGI Genomics is the world’s leading provider of genomic sequencing and proteomic services, serving customers in more than 100 countries. As ELC Biogen’s technology partner, BGI Genomics equips our laboratory with integrated sequencing and proteomic solutions for academic institutions, pharmaceutical companies, healthcare providers, and research organizations.

With more than 20 years of genomics experience, BGI Genomics helps organizations achieve their research goals by delivering rapid, high-quality results through a broad array of cost-effective, cutting-edge technologies — including its own innovative DNBSEQ™ sequencing platform that underpins the precision testing services offered through ELC Biogen.

Areas of Application

Our partnership with BGI Genomics extends ELC Biogen’s diagnostic and research capabilities across a broad range of applications, including:
  1. Clinical research in human health
  2. Basic research covering human, plant, animal, and microbial species
  3. Genetic testing and screening
  4. Drug discovery and development
  5. Agriculture, biodiversity preservation, and sustainability

DNBSEQ™ Sequencing Technology

BGI Genomics’ proprietary DNBSEQ™ platforms deliver high-throughput, cost-effective sequencing data with industry-leading accuracy — the same technology foundation ELC Biogen relies on for its NGS-based diagnostic panels and research services.

WHAT'S NEW

News & Updates

Discover recent achievements, healthcare updates, research highlights, and important announcements from ELC Biogen.